Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries

We are analyzing https://link.springer.com/article/10.1007/s10585-016-9786-x.

Title:
Effect of bexarotene on differentiation of glioblastoma multiforme compared with ATRA | Clinical & Experimental Metastasis
Description:
Glioblastoma multiforme (GBM) is the most aggressive malignant brain tumor. Since differentiation can attenuate or halt the growth of tumor cells, an image-based phenotypic screening was performed to find out drugs inducing morphological differentiation of GBMs. Bexarotene, a selective retinoid X receptor agonist, showed strong inhibition of neurospheroidal colony formation and migration of cultured primary GBM cells. Bexarotene treatment reduced nestin expression, while significantly increasing glial fibrillary acidic protein (GFAP) expression. The effect of bexarotene on gene expression profile was compared with the activity of all-trans retinoic acid (ATRA), a well-known differentiation inducer. Both drugs largely altered the gene expression pattern into a tumor-ameliorating direction. These drugs increased the gene expression levels of Krüppel-like factor 9 (KLF9), regulator of G-protein signaling 4 (RGS4), growth differentiation factor 15 (GDF15), angiopoietin-like protein 4 (ANGPTL4), and lowered the level of chemokine receptor type 4 (CXCR4). However, transglutaminase 2 (TG2) induction, an adverse effect of ATRA, was much weaker in bexarotene treated primary GBM cells. Consistently, the TG2 enzymatic activity was negligibly affected by bexarotene treatment. It is important to control TG2 overexpression since its upregulation is correlated with tumor transformation and drug resistance. Bexarotene also showed in vivo tumoricidal effects in a GBM xenograft mouse model. Therefore, we suggest bexarotene as a more beneficial differentiation agent than ATRA for GBM.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,643,328 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

pubmed, article, google, scholar, cas, cancer, cells, central, res, expression, glioblastoma, cell, bexarotene, differentiation, receptor, retinoic, human, factor, chemokine, transglutaminase, research, acid, clin, stem, lee, brain, alltrans, analysis, multiforme, atra, gbm, gene, korea, access, privacy, cookies, content, data, metastasis, effect, heo, tumor, glial, cxcr, glioma, tumors, identification, carcinoma, kruppellike, author,

Topics {✒️}

ji-hwan park month download article/chapter late-phase neuronal maturation sh-sy5y neuroblastoma cells image-based phenotypic screening trans retinoic acid gene expression profile central nervous system chemokine receptor-directed compounds transcriptomic profiles reveals glutathione s-transferase p-1 glioblastoma stem cells full article pdf cancer stem cell cell-based immunotherapy glioblastoma multiforme compared pharmacology research group heeyeong cho article heo privacy choices/manage cookies mapk-dependent manner functional anti-mir-9 korea research institute regulates cxcr4 expression glioblastoma patients treated mediated cell migration tissue transglutaminase expression korean research council plant aging research corneal endothelial cells xeno-related rejection alkylation dna damage tissue transglutaminase leads tae-hoon jung cd133-negative cells related subjects cultured human astrocytes major chemokine receptor retinoic acid beneficial differentiation agent glial primary murine astrocytes growth/differentiation factor-15 hyun young kim vivo tumoricidal effects human astrocytic gliomas g-protein signaling 4 indatraline inhibits rho suppresses notch1 signaling small-molecule antagonist

Questions {❓}

  • Vanhara P et al (2012) Growth/differentiation factor-15: prostate cancer suppressor or promoter?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Effect of bexarotene on differentiation of glioblastoma multiforme compared with ATRA
         description:Glioblastoma multiforme (GBM) is the most aggressive malignant brain tumor. Since differentiation can attenuate or halt the growth of tumor cells, an image-based phenotypic screening was performed to find out drugs inducing morphological differentiation of GBMs. Bexarotene, a selective retinoid X receptor agonist, showed strong inhibition of neurospheroidal colony formation and migration of cultured primary GBM cells. Bexarotene treatment reduced nestin expression, while significantly increasing glial fibrillary acidic protein (GFAP) expression. The effect of bexarotene on gene expression profile was compared with the activity of all-trans retinoic acid (ATRA), a well-known differentiation inducer. Both drugs largely altered the gene expression pattern into a tumor-ameliorating direction. These drugs increased the gene expression levels of Krüppel-like factor 9 (KLF9), regulator of G-protein signaling 4 (RGS4), growth differentiation factor 15 (GDF15), angiopoietin-like protein 4 (ANGPTL4), and lowered the level of chemokine receptor type 4 (CXCR4). However, transglutaminase 2 (TG2) induction, an adverse effect of ATRA, was much weaker in bexarotene treated primary GBM cells. Consistently, the TG2 enzymatic activity was negligibly affected by bexarotene treatment. It is important to control TG2 overexpression since its upregulation is correlated with tumor transformation and drug resistance. Bexarotene also showed in vivo tumoricidal effects in a GBM xenograft mouse model. Therefore, we suggest bexarotene as a more beneficial differentiation agent than ATRA for GBM.
         datePublished:2016-03-08T00:00:00Z
         dateModified:2016-03-08T00:00:00Z
         pageStart:417
         pageEnd:429
         sameAs:https://doi.org/10.1007/s10585-016-9786-x
         keywords:
            Bexarotene
            All-trans retinoic acid
            GBM
            Glioblastoma multiforme
            Transglutaminase 2
            Cancer Research
            Biomedicine
            general
            Oncology
            Hematology
            Surgical Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-016-9786-x/MediaObjects/10585_2016_9786_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-016-9786-x/MediaObjects/10585_2016_9786_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-016-9786-x/MediaObjects/10585_2016_9786_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-016-9786-x/MediaObjects/10585_2016_9786_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-016-9786-x/MediaObjects/10585_2016_9786_Fig5_HTML.gif
         isPartOf:
            name:Clinical & Experimental Metastasis
            issn:
               1573-7276
               0262-0898
            volumeNumber:33
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Netherlands
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Jin-Chul Heo
               affiliation:
                     name:Korea Research Institute of Chemical Technology (KRICT)
                     address:
                        name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tae-Hoon Jung
               affiliation:
                     name:Korea Research Institute of Chemical Technology (KRICT)
                     address:
                        name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
                        type:PostalAddress
                     type:Organization
                     name:University of Science and Technology (UST)
                     address:
                        name:Pharmacology Research Medicinal and Pharmaceutical Chemistry, University of Science and Technology (UST), Daejeon, Republic of Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sungjin Lee
               affiliation:
                     name:Korea Research Institute of Chemical Technology (KRICT)
                     address:
                        name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hyun Young Kim
               affiliation:
                     name:Korea Research Institute of Chemical Technology (KRICT)
                     address:
                        name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gildon Choi
               affiliation:
                     name:Korea Research Institute of Chemical Technology (KRICT)
                     address:
                        name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Myungeun Jung
               affiliation:
                     name:Korea Research Institute of Chemical Technology (KRICT)
                     address:
                        name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Daeyoung Jung
               affiliation:
                     name:Korea Research Institute of Chemical Technology (KRICT)
                     address:
                        name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Heung Kyoung Lee
               affiliation:
                     name:Korea Research Institute of Chemical Technology (KRICT)
                     address:
                        name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jung-Ok Lee
               affiliation:
                     name:Korea Research Institute of Chemical Technology (KRICT)
                     address:
                        name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ji-Hwan Park
               affiliation:
                     name:POSTECH
                     address:
                        name:Department of Chemical Engineering, POSTECH, Pohang, Republic of Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Daehee Hwang
               affiliation:
                     name:Institute for Basic Science
                     address:
                        name:Department of New Biology and Center for Plant Aging Research, Institute for Basic Science, Daegu, Republic of Korea
                        type:PostalAddress
                     type:Organization
                     name:POSTECH
                     address:
                        name:Department of Chemical Engineering, POSTECH, Pohang, Republic of Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ho Jun Seol
               affiliation:
                     name:Sungkyunkwan University School of Medicine
                     address:
                        name:Department of Neurosurgery, Samsung Medical Center (SMC), Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Heeyeong Cho
               affiliation:
                     name:Korea Research Institute of Chemical Technology (KRICT)
                     address:
                        name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
                        type:PostalAddress
                     type:Organization
                     name:University of Science and Technology (UST)
                     address:
                        name:Pharmacology Research Medicinal and Pharmaceutical Chemistry, University of Science and Technology (UST), Daejeon, Republic of Korea
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Effect of bexarotene on differentiation of glioblastoma multiforme compared with ATRA
      description:Glioblastoma multiforme (GBM) is the most aggressive malignant brain tumor. Since differentiation can attenuate or halt the growth of tumor cells, an image-based phenotypic screening was performed to find out drugs inducing morphological differentiation of GBMs. Bexarotene, a selective retinoid X receptor agonist, showed strong inhibition of neurospheroidal colony formation and migration of cultured primary GBM cells. Bexarotene treatment reduced nestin expression, while significantly increasing glial fibrillary acidic protein (GFAP) expression. The effect of bexarotene on gene expression profile was compared with the activity of all-trans retinoic acid (ATRA), a well-known differentiation inducer. Both drugs largely altered the gene expression pattern into a tumor-ameliorating direction. These drugs increased the gene expression levels of Krüppel-like factor 9 (KLF9), regulator of G-protein signaling 4 (RGS4), growth differentiation factor 15 (GDF15), angiopoietin-like protein 4 (ANGPTL4), and lowered the level of chemokine receptor type 4 (CXCR4). However, transglutaminase 2 (TG2) induction, an adverse effect of ATRA, was much weaker in bexarotene treated primary GBM cells. Consistently, the TG2 enzymatic activity was negligibly affected by bexarotene treatment. It is important to control TG2 overexpression since its upregulation is correlated with tumor transformation and drug resistance. Bexarotene also showed in vivo tumoricidal effects in a GBM xenograft mouse model. Therefore, we suggest bexarotene as a more beneficial differentiation agent than ATRA for GBM.
      datePublished:2016-03-08T00:00:00Z
      dateModified:2016-03-08T00:00:00Z
      pageStart:417
      pageEnd:429
      sameAs:https://doi.org/10.1007/s10585-016-9786-x
      keywords:
         Bexarotene
         All-trans retinoic acid
         GBM
         Glioblastoma multiforme
         Transglutaminase 2
         Cancer Research
         Biomedicine
         general
         Oncology
         Hematology
         Surgical Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-016-9786-x/MediaObjects/10585_2016_9786_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-016-9786-x/MediaObjects/10585_2016_9786_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-016-9786-x/MediaObjects/10585_2016_9786_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-016-9786-x/MediaObjects/10585_2016_9786_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-016-9786-x/MediaObjects/10585_2016_9786_Fig5_HTML.gif
      isPartOf:
         name:Clinical & Experimental Metastasis
         issn:
            1573-7276
            0262-0898
         volumeNumber:33
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Netherlands
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Jin-Chul Heo
            affiliation:
                  name:Korea Research Institute of Chemical Technology (KRICT)
                  address:
                     name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tae-Hoon Jung
            affiliation:
                  name:Korea Research Institute of Chemical Technology (KRICT)
                  address:
                     name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
                     type:PostalAddress
                  type:Organization
                  name:University of Science and Technology (UST)
                  address:
                     name:Pharmacology Research Medicinal and Pharmaceutical Chemistry, University of Science and Technology (UST), Daejeon, Republic of Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sungjin Lee
            affiliation:
                  name:Korea Research Institute of Chemical Technology (KRICT)
                  address:
                     name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hyun Young Kim
            affiliation:
                  name:Korea Research Institute of Chemical Technology (KRICT)
                  address:
                     name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gildon Choi
            affiliation:
                  name:Korea Research Institute of Chemical Technology (KRICT)
                  address:
                     name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Myungeun Jung
            affiliation:
                  name:Korea Research Institute of Chemical Technology (KRICT)
                  address:
                     name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Daeyoung Jung
            affiliation:
                  name:Korea Research Institute of Chemical Technology (KRICT)
                  address:
                     name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Heung Kyoung Lee
            affiliation:
                  name:Korea Research Institute of Chemical Technology (KRICT)
                  address:
                     name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jung-Ok Lee
            affiliation:
                  name:Korea Research Institute of Chemical Technology (KRICT)
                  address:
                     name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ji-Hwan Park
            affiliation:
                  name:POSTECH
                  address:
                     name:Department of Chemical Engineering, POSTECH, Pohang, Republic of Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Daehee Hwang
            affiliation:
                  name:Institute for Basic Science
                  address:
                     name:Department of New Biology and Center for Plant Aging Research, Institute for Basic Science, Daegu, Republic of Korea
                     type:PostalAddress
                  type:Organization
                  name:POSTECH
                  address:
                     name:Department of Chemical Engineering, POSTECH, Pohang, Republic of Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ho Jun Seol
            affiliation:
                  name:Sungkyunkwan University School of Medicine
                  address:
                     name:Department of Neurosurgery, Samsung Medical Center (SMC), Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Heeyeong Cho
            affiliation:
                  name:Korea Research Institute of Chemical Technology (KRICT)
                  address:
                     name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
                     type:PostalAddress
                  type:Organization
                  name:University of Science and Technology (UST)
                  address:
                     name:Pharmacology Research Medicinal and Pharmaceutical Chemistry, University of Science and Technology (UST), Daejeon, Republic of Korea
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Clinical & Experimental Metastasis
      issn:
         1573-7276
         0262-0898
      volumeNumber:33
Organization:
      name:Springer Netherlands
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Korea Research Institute of Chemical Technology (KRICT)
      address:
         name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
         type:PostalAddress
      name:Korea Research Institute of Chemical Technology (KRICT)
      address:
         name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
         type:PostalAddress
      name:University of Science and Technology (UST)
      address:
         name:Pharmacology Research Medicinal and Pharmaceutical Chemistry, University of Science and Technology (UST), Daejeon, Republic of Korea
         type:PostalAddress
      name:Korea Research Institute of Chemical Technology (KRICT)
      address:
         name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
         type:PostalAddress
      name:Korea Research Institute of Chemical Technology (KRICT)
      address:
         name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
         type:PostalAddress
      name:Korea Research Institute of Chemical Technology (KRICT)
      address:
         name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
         type:PostalAddress
      name:Korea Research Institute of Chemical Technology (KRICT)
      address:
         name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
         type:PostalAddress
      name:Korea Research Institute of Chemical Technology (KRICT)
      address:
         name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
         type:PostalAddress
      name:Korea Research Institute of Chemical Technology (KRICT)
      address:
         name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
         type:PostalAddress
      name:Korea Research Institute of Chemical Technology (KRICT)
      address:
         name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
         type:PostalAddress
      name:POSTECH
      address:
         name:Department of Chemical Engineering, POSTECH, Pohang, Republic of Korea
         type:PostalAddress
      name:Institute for Basic Science
      address:
         name:Department of New Biology and Center for Plant Aging Research, Institute for Basic Science, Daegu, Republic of Korea
         type:PostalAddress
      name:POSTECH
      address:
         name:Department of Chemical Engineering, POSTECH, Pohang, Republic of Korea
         type:PostalAddress
      name:Sungkyunkwan University School of Medicine
      address:
         name:Department of Neurosurgery, Samsung Medical Center (SMC), Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
         type:PostalAddress
      name:Korea Research Institute of Chemical Technology (KRICT)
      address:
         name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
         type:PostalAddress
      name:University of Science and Technology (UST)
      address:
         name:Pharmacology Research Medicinal and Pharmaceutical Chemistry, University of Science and Technology (UST), Daejeon, Republic of Korea
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Jin-Chul Heo
      affiliation:
            name:Korea Research Institute of Chemical Technology (KRICT)
            address:
               name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
               type:PostalAddress
            type:Organization
      name:Tae-Hoon Jung
      affiliation:
            name:Korea Research Institute of Chemical Technology (KRICT)
            address:
               name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
               type:PostalAddress
            type:Organization
            name:University of Science and Technology (UST)
            address:
               name:Pharmacology Research Medicinal and Pharmaceutical Chemistry, University of Science and Technology (UST), Daejeon, Republic of Korea
               type:PostalAddress
            type:Organization
      name:Sungjin Lee
      affiliation:
            name:Korea Research Institute of Chemical Technology (KRICT)
            address:
               name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
               type:PostalAddress
            type:Organization
      name:Hyun Young Kim
      affiliation:
            name:Korea Research Institute of Chemical Technology (KRICT)
            address:
               name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
               type:PostalAddress
            type:Organization
      name:Gildon Choi
      affiliation:
            name:Korea Research Institute of Chemical Technology (KRICT)
            address:
               name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
               type:PostalAddress
            type:Organization
      name:Myungeun Jung
      affiliation:
            name:Korea Research Institute of Chemical Technology (KRICT)
            address:
               name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
               type:PostalAddress
            type:Organization
      name:Daeyoung Jung
      affiliation:
            name:Korea Research Institute of Chemical Technology (KRICT)
            address:
               name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
               type:PostalAddress
            type:Organization
      name:Heung Kyoung Lee
      affiliation:
            name:Korea Research Institute of Chemical Technology (KRICT)
            address:
               name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
               type:PostalAddress
            type:Organization
      name:Jung-Ok Lee
      affiliation:
            name:Korea Research Institute of Chemical Technology (KRICT)
            address:
               name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
               type:PostalAddress
            type:Organization
      name:Ji-Hwan Park
      affiliation:
            name:POSTECH
            address:
               name:Department of Chemical Engineering, POSTECH, Pohang, Republic of Korea
               type:PostalAddress
            type:Organization
      name:Daehee Hwang
      affiliation:
            name:Institute for Basic Science
            address:
               name:Department of New Biology and Center for Plant Aging Research, Institute for Basic Science, Daegu, Republic of Korea
               type:PostalAddress
            type:Organization
            name:POSTECH
            address:
               name:Department of Chemical Engineering, POSTECH, Pohang, Republic of Korea
               type:PostalAddress
            type:Organization
      name:Ho Jun Seol
      affiliation:
            name:Sungkyunkwan University School of Medicine
            address:
               name:Department of Neurosurgery, Samsung Medical Center (SMC), Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
               type:PostalAddress
            type:Organization
      name:Heeyeong Cho
      affiliation:
            name:Korea Research Institute of Chemical Technology (KRICT)
            address:
               name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
               type:PostalAddress
            type:Organization
            name:University of Science and Technology (UST)
            address:
               name:Pharmacology Research Medicinal and Pharmaceutical Chemistry, University of Science and Technology (UST), Daejeon, Republic of Korea
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
      name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
      name:Pharmacology Research Medicinal and Pharmaceutical Chemistry, University of Science and Technology (UST), Daejeon, Republic of Korea
      name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
      name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
      name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
      name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
      name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
      name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
      name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
      name:Department of Chemical Engineering, POSTECH, Pohang, Republic of Korea
      name:Department of New Biology and Center for Plant Aging Research, Institute for Basic Science, Daegu, Republic of Korea
      name:Department of Chemical Engineering, POSTECH, Pohang, Republic of Korea
      name:Department of Neurosurgery, Samsung Medical Center (SMC), Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
      name:Drug Discovery Division, Pharmacology Research Group, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea
      name:Pharmacology Research Medicinal and Pharmaceutical Chemistry, University of Science and Technology (UST), Daejeon, Republic of Korea
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(252)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

4.04s.